These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 1353337)
1. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. German DC; Manaye KF; Sonsalla PK; Brooks BA Ann N Y Acad Sci; 1992 May; 648():42-62. PubMed ID: 1353337 [TBL] [Abstract][Full Text] [Related]
2. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. Lavoie B; Parent A Neuroreport; 1991 Oct; 2(10):601-4. PubMed ID: 1684519 [TBL] [Abstract][Full Text] [Related]
3. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Liang CL; Sinton CM; Sonsalla PK; German DC Neurodegeneration; 1996 Dec; 5(4):313-8. PubMed ID: 9117542 [TBL] [Abstract][Full Text] [Related]
4. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin. Liang CL; Sinton CM; German DC Neuroscience; 1996 Nov; 75(2):523-33. PubMed ID: 8931015 [TBL] [Abstract][Full Text] [Related]
5. Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice. Gaspar P; Ben Jelloun N; Febvret A Neuroscience; 1994 Jul; 61(2):293-305. PubMed ID: 7969910 [TBL] [Abstract][Full Text] [Related]
6. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? German DC; Dubach M; Askari S; Speciale SG; Bowden DM Neuroscience; 1988 Jan; 24(1):161-74. PubMed ID: 3259295 [TBL] [Abstract][Full Text] [Related]
7. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275 [TBL] [Abstract][Full Text] [Related]
8. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. German DC; Nelson EL; Liang CL; Speciale SG; Sinton CM; Sonsalla PK Neurodegeneration; 1996 Dec; 5(4):299-312. PubMed ID: 9117541 [TBL] [Abstract][Full Text] [Related]
9. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration. McCormack AL; Atienza JG; Langston JW; Di Monte DA Neuroscience; 2006 Aug; 141(2):929-937. PubMed ID: 16677770 [TBL] [Abstract][Full Text] [Related]
10. GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys. Herrero MT; Perez-Otaño I; Oset C; Kastner A; Hirsch EC; Agid Y; Luquin MR; Obeso JA; Del Rio J Neuroscience; 1993 Oct; 56(4):965-72. PubMed ID: 7904332 [TBL] [Abstract][Full Text] [Related]
11. Expression of calbindin D28K in the dopaminergic mesotelencephalic system in embryonic and fetal human brain. Verney C; Zecevic N; Ezan P J Comp Neurol; 2001 Jan; 429(1):45-58. PubMed ID: 11086288 [TBL] [Abstract][Full Text] [Related]
12. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice. Airaksinen MS; Thoenen H; Meyer M Eur J Neurosci; 1997 Jan; 9(1):120-7. PubMed ID: 9042576 [TBL] [Abstract][Full Text] [Related]
13. MPTP-induced parkinsonism: relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeys. Elsworth JD; Deutch AY; Redmond DE; Sladek JR; Roth RH Brain Res; 1990 Apr; 513(2):320-4. PubMed ID: 2350702 [TBL] [Abstract][Full Text] [Related]
14. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes. Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824 [TBL] [Abstract][Full Text] [Related]
15. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. German DC; Manaye K; Smith WK; Woodward DJ; Saper CB Ann Neurol; 1989 Oct; 26(4):507-14. PubMed ID: 2817827 [TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP. Sanghera MK; Manaye K; McMahon A; Sonsalla PK; German DC Neuroreport; 1997 Oct; 8(15):3327-31. PubMed ID: 9351666 [TBL] [Abstract][Full Text] [Related]
17. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration. Pérez-Otaño I; Oset C; Luquin MR; Herrero MT; Obeso JA; Del Río J Neurosci Lett; 1994 Jul; 175(1-2):121-5. PubMed ID: 7970192 [TBL] [Abstract][Full Text] [Related]
18. Low dopamine transporter mRNA levels in midbrain regions containing calbindin. Sanghera MK; Manaye KF; Liang CL; Lacopino AM; Bannon MJ; German DC Neuroreport; 1994 Aug; 5(13):1641-4. PubMed ID: 7819538 [TBL] [Abstract][Full Text] [Related]
19. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Schneider JS; Yuwiler A; Markham CH Brain Res; 1987 May; 411(1):144-50. PubMed ID: 2886180 [TBL] [Abstract][Full Text] [Related]